Clinical pathological factors | n 108 | SSTR-2 mRNA | P value | SSTR-3 mRNA | P value | SSTR-5 mRNA | P value | |||
---|---|---|---|---|---|---|---|---|---|---|
Positive ( n = 88) | Negative ( n = 20) | Positive ( n = 75) | Negative ( n = 33) | Positive ( n = 14) | Negative ( n = 94) | |||||
Gender | P < 0.05** | P < 0.05** | P > 0.05 | |||||||
Male | 56 | 40 | 16 | 33 | 23 | 8 | 48 | |||
Female | 52 | 48 | 4 | 42 | 10 | 6 | 46 | |||
Age (years) | P > 0.05 | P > 0.05 | P > 0.05 | |||||||
<60 | 40 68 36 32 22 46 | 35 68 36 32 22 46 | 5 | 27 68 36 32 22 46 | 13 | 5 | 35 | |||
≥60 | 68 | 53 | 15 | 48 | 20 | 9 | 59 | |||
T stage | P > 0.05 | P > 0.05 | P > 0.05 | |||||||
T1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | |||
T2 | 13 | 11 | 2 | 9 | 5 | 2 | 11 | |||
T3 | 45 | 36 | 9 | 35 | 10 | 5 | 40 | |||
T4 | 49 | 41 | 8 | 32 | 17 | 7 | 42 | |||
N stage | P > 0.05 | P > 0.05 | P > 0.05 | |||||||
N0 | 63 | 53 | 10 | 42 | 21 | 7 | 56 | |||
N1 | 34 | 28 | 6 | 25 | 9 | 5 | 29 | |||
N2 | 11 | 7 | 4 | 8 | 3 | 2 | 9 | |||
M stage | P > 0.05 | P > 0.05 | P > 0.05 | |||||||
M0 | 84 | 67 | 17 | 58 | 26 | 9 | 75 | |||
M1 | 24 | 21 | 3 | 17 | 7 | 5 | 19 | |||
TNM stage | P > 0.05 | P > 0.05 | P > 0.05 | |||||||
I to II | 40 | 31 | 9 | 27 | 13 | 6 | 34 | |||
III to IV | 68 | 57 | 11 | 48 | 20 | 8 | 60 | |||
Differentiation | P > 0.05 | P > 0.05 | P > 0.05 | |||||||
Well | 40 | 33 | 7 | 30 | 10 | 4 | 36 | |||
Moderate | 45 | 35 | 10 | 29 | 16 | 5 | 40 | |||
Poor/undifferentiated | 23 | 20 | 3 | 16 | 7 | 5 | 18 | |||
Survival (60-month follow-up) | P < 0.05* | P > 0.05 | P > 0.05 | |||||||
Death | 90 | 70 | 20 | 63 | 27 | 11 | 79 | |||
Censored | 18 | 18 | 0 | 12 | 6 | 3 | 15 |